Literature DB >> 28233308

An estimate of the number of people in Italy living after a childhood cancer.

Silvia Francisci1, Stefano Guzzinati2, Luigino Dal Maso3, Carlotta Sacerdote4, Carlotta Buzzoni5,6, Anna Gigli7.   

Abstract

Cancers diagnosed in children below the age of 15 years represent 1.2% of all cancer cases, and survival after a childhood cancer has greatly improved over the past 40 years in all high income countries. This study aims to estimate the number of people living in Italy after a childhood cancer for all cancers combined and for a selection of cancer types. We computed 15-year prevalence using data from 15 Italian population-based cancer registries (covering 19% of Italian population) and estimated complete prevalence for Italy by using the CHILDPREV method, implemented in the COMPREV software. A total of 44,135 persons were alive at January 1st, 2010 after a cancer diagnosed during childhood. This number corresponds to a proportion of 73 per 100,000 Italians and to about 2% of all prevalent cases. Among them, 54% were males and 64% had survived after being diagnosed before 1995, the start of the observation period. A quarter of all childhood prevalent cases were diagnosed with brain and central nervous system tumors, a quarter with acute lymphoid leukemia, and 7% with Hodgkin lymphoma. Nearly a quarter of prevalent patients were aged 40 years and older. Information about the number of people living after a childhood cancer in Italy by cancer type and their specific health care needs may be helpful to health-care planners and clinicians in the development of guidelines aimed to reduce the burden of late effect of treatments during childhood.
© 2017 UICC.

Entities:  

Keywords:  Italy; childhood cancer; incidence; prevalence; survival

Mesh:

Year:  2017        PMID: 28233308     DOI: 10.1002/ijc.30665

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  1 in total

1.  Characteristics of people living in Italy after a cancer diagnosis in 2010 and projections to 2020.

Authors:  Stefano Guzzinati; Saverio Virdone; Roberta De Angelis; Chiara Panato; Carlotta Buzzoni; Riccardo Capocaccia; Silvia Francisci; Anna Gigli; Manuel Zorzi; Giovanna Tagliabue; Diego Serraino; Fabio Falcini; Claudia Casella; Antonio Giampiero Russo; Fabrizio Stracci; Bianca Caruso; Maria Michiara; Anna Luisa Caiazzo; Marine Castaing; Stefano Ferretti; Lucia Mangone; Giuseppa Rudisi; Flavio Sensi; Guido Mazzoleni; Fabio Pannozzo; Rosario Tumino; Mario Fusco; Paolo Ricci; Gemma Gola; Adriano Giacomin; Francesco Tisano; Giuseppa Candela; Anna Clara Fanetti; Filomena Pala; Antonella Sutera Sardo; Massimo Rugge; Laura Botta; Luigino Dal Maso
Journal:  BMC Cancer       Date:  2018-02-09       Impact factor: 4.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.